| Issue |
Title |
File |
| Vol 21, No 4 (2023) |
Idealization in pharmacology and pharmacy: Symbol of the chemical formula of one molecule of a substance and a real pharmaceutical product |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 21, No 4 (2023) |
Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons |
(Rus)
|
|
Urakov A.L., Nikitina I.L., Klen E.E., Wang Y., Samorodov A.V.
|
| Vol 21, No 4 (2023) |
Bacteriophages: Clinical significance and application prospects |
(Rus)
|
|
Danilov A.I., Evseev A.V.
|
| Vol 21, No 4 (2023) |
Pyolytics as a product of the physical–chemical repurposing of antiseptics and an alternative to larval therapy for chronic wounds |
(Rus)
(Eng)
|
|
Urakov A.L., Urakova N.A., Reshetnikov A.P., Shabanov P.D., Wang Y., Bodduluri P.V., Samorodov A.V., Rozov R.A., Shchemeleva A.A., Novikov V.E., Pozhilova E.V.
|
| Vol 21, No 3 (2023) |
Clinical manifestations and mechanisms of formation of neurological disorders in patients with vibration disease |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S.
|
| Vol 21, No 3 (2023) |
Physical-chemical repurposing of drugs. History of its formation in Russia |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 21, No 3 (2023) |
Role of oxidative stress in the pathogenesis of autism spectrum disorders |
(Rus)
|
|
Belokoskova S.G., Tsikunov S.G.
|
| Vol 21, No 3 (2023) |
Modern representations about signaling pathways and protective mechanisms of ferroptosis. A biological role of diffusion of death signals of ferroptotic cells |
(Rus)
|
|
Vashchenko V.I., Sorocoletova E.F., Shabanov P.D.
|
| Vol 21, No 2 (2023) |
Alkaline hydrogen peroxide solutions: expectorant, pyolytic, mucolytic, haemolytic, oxygen-releasing, and decolorizing effects |
(Rus)
|
|
Fisher E.L., Urakov A.L., Samorodov A.V., Bashirov I.I., Shabanov P.D.
|
| Vol 21, No 2 (2023) |
Circular RNAs — a modern perspective on the molecular mechanisms of neurologic diseases in humans and prospects for therapeutic agents |
(Rus)
|
|
Shabanov P.D., Vashchenko V.I., Savelieva L.P., Romashova Y.E.
|
| Vol 21, No 1 (2023) |
Prospects of pharmacological regulation of aquaporin function in CNS diseases |
(Rus)
|
|
Ponamareva N.S., Novikov V.E., Pozhilova E.V.
|
| Vol 21, No 1 (2023) |
Immune status and cytokine spectrum as predictive signs of the severity of the disease and the effectiveness of intensive care in patients with coronavirus infection COVID-19 |
(Rus)
|
|
Sadykov V.F., Poltavtseva R.A., Chaplygina A.V., Bobkova N.V.
|
| Vol 21, No 1 (2023) |
Toxicology of carbon nanostructures. Part 2. Nanoscale materials based on graphene sheets |
(Rus)
|
|
Litasova E.V., Iljin V.V., Brusina M.A., Piotrovskiy L.B.
|
| Vol 20, No 4 (2022) |
Sacubitril/valsartan as a component of therapy for chronic heart failure |
(Rus)
|
|
Danilov A.I., Evseev A.V., Evseeva M.A., Pavluchenkova O.V., Pereverzev V.A.
|
| Vol 20, No 4 (2022) |
Biochemical mechanisms of the energy-protective action of blockers of slow high-threshold L-type calcium channels |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S., Shabanov P.D.
|
| Vol 20, No 4 (2022) |
The possibilities of chiral drugs |
(Rus)
|
|
Lenskaya K.V., Kurbanov R.A., Bagaturiya G.O., Grishin V.V., Proshin S.N.
|
| Vol 20, No 4 (2022) |
Circular RNAs in eukaryotic cells: origin, characteristics, mechanisms of molecular functioning in human malignant diseases |
(Rus)
|
|
Vashchenko V.I., Chuklovin A.B., Shabanov P.D.
|
| Vol 20, No 3 (2022) |
Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics |
(Rus)
|
|
Gurevich K.G., Sorokina Y.A., Urakov A.L., Sinyushkina S.D., Pryazhnikova M.I., Gorinova A.V., Lovtsova L.V., Zanozina O.V.
|
| Vol 20, No 3 (2022) |
Peculiarities of carbamazepine pharmacogenetics and the most common adverse drug reactions during its use (literature review) |
(Rus)
|
|
Skryabin V.Y., Zastrozhin M.S., Bryun E.A., Sychev D.A.
|
| Vol 20, No 3 (2022) |
Ghrelin mechanisms of food reward. Part 2. Interaction of ghrelin with hormones, neuropeptides and other endogenous ligands |
(Rus)
|
|
Reikhardt B.A., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Ghrelin-dependent mechanisms of food reward. Part 1. Ghrelin and dopamine |
(Rus)
|
|
Reikhardt B.A., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Role of glutamate receptor complex in the organism. Ligands of NMDA receptors in neurodegenerative processes – a modern state of the problem |
(Rus)
|
|
Dergachev V.D., Yakovleva E.E., Bychkov E.R., Piotrovskiy L.B., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Toxicology of carbon nanostructures. Part I. Spherical nanoparticles (fullerenes and nanoonions) |
(Rus)
|
|
Litasova E.V., Iljin V.V., Myznikov L.V., Piotrovskiy L.B.
|
| Vol 19, No 4 (2021) |
Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy |
(Rus)
|
|
Vashchenko V.I., Romashova J.E., Shabanov P.D.
|
| Vol 19, No 4 (2021) |
Acute respiratory syndrome-2 (SARS-CoV-2): A solution of hydrogen peroxide and sodium bicarbonate as an expectorant for recanalization of the respiratory tract and blood oxygenation in respiratory obstruction (review) |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 19, No 3 (2021) |
Molecular mechanisms of antiatherogenic drugs action |
(Rus)
|
|
Lizunov A.V., Bychkov E.R.
|
| Vol 19, No 3 (2021) |
Antioxidant and prooxidant systems in patients with ischemic insult |
(Rus)
|
|
Belokoskova S.G., Tsikunov S.G.
|
| Vol 19, No 3 (2021) |
Mechanisms and triggers of adaptation to hypoxia |
(Rus)
|
|
Lyubimov A.V., Cherkashin D.V., Efimov S.V., Alanichev A.E., Ivanov V.S., Kutelev G.G.
|
| Vol 19, No 3 (2021) |
Possibilities of pharmacological correction of reperfusion injury of ischemic myocardium (review) |
(Rus)
|
|
Gurevich K.G., Urakov A.L., Fisher E.L., Abzalilov T.A., Khairzamanova K.A., Yagudin T.A., Samorodov A.V.
|
| Vol 19, No 3 (2021) |
Silver nanoparticles: safety and efficiency for human health |
(Rus)
|
|
Morozova Y.A., Dergachev D.S., Subotyalov M.A.
|
| Vol 19, No 2 (2021) |
Temperature, osmotic and acidic activity of infusion solutions as an integral part of their mechanism of action |
(Rus)
|
|
Urakova N.A.
|
| Vol 19, No 2 (2021) |
Biological role of miRNA-146a at virus infections. Modern strategy of search of new safe pharmacological agents for treatment |
(Rus)
|
|
Shabanov P.D., Vashchenko V.I.
|
| Vol 19, No 2 (2021) |
Direct cardial effects and mechanisms of cardiovascular action of gliflosins |
(Rus)
|
|
Zverev Y.F., Rykunova A.Y.
|
| Vol 19, No 1 (2021) |
Zinc, brain, behavior |
(Rus)
|
|
Yakimovskii А.F.
|
| Vol 19, No 1 (2021) |
Proposed mechanisms of systemic cardiovascular action of gliflosins |
(Rus)
|
|
Zverev Y.F., Rykunova A.Y.
|
| Vol 18, No 4 (2020) |
How to improve the selectivity of drugs |
(Rus)
|
|
Dumpis M.A., Brusina M.A., Litasova E.V., Iljin V.V., Nikolayev D.N., Piotrovskiy L.B.
|
| Vol 18, No 4 (2020) |
Oxidative stress as a problem of psychopharmacology |
(Rus)
|
|
Arushanyan E.B., Naumov S.S.
|
| Vol 18, No 4 (2020) |
Strategies for search of pharmacological drugs against SARS-CoV-2 on the base of studying the structural-genetic features of coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 |
(Rus)
|
|
Vashchenko V.I., Vilyaninov V.N., Shabanov P.D.
|
| Vol 18, No 3 (2020) |
Pathophysiological mechanisms of neurological disorders in experimental animals exposed to vibration |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S., Shabanov P.D.
|
| Vol 18, No 3 (2020) |
Relief of microecological imbalances and barrier dysfunction of the intestinal mucosa in a therapeutic strategy for life-threatening conditions |
(Rus)
|
|
Chepur S.V., Pluzhnikov N.N., Chubar’ O.V., Cygan V.N., Bakulina L.S., Sidorov S.P., Bazhenov M.V., Mosin A.V., Vinogradov M.V., Semakin R.V.
|
| Vol 18, No 3 (2020) |
Properties and biological potential of single wall carbon nanohorns (SWCNH) |
(Rus)
|
|
Piotrovskiy L.B., Kudryavtseva T.A., Litasova E.V.
|
| Vol 18, No 2 (2020) |
Role of extracellular vesicles in nephrology. Prospective use in therapy of kidneys and urinary tract diseases |
(Rus)
|
|
Vashchenko V.I., Shabanov P.D.
|
| Vol 18, No 1 (2020) |
Neurochemical mechanisms and pharmacology of ghrelins |
(Rus)
|
|
Shabanov P.D., Lebedev A.A., Bychkov E.R., Lavrov N.V., Morozov V.I.
|
| Vol 17, No 4 (2019) |
Mitochondrial dysfunctions and antihypoxants |
(Eng)
|
|
Novikov V.E., Levchenkova O.S., Ivantsova E.N., Vorobieva V.V.
|
| Vol 17, No 4 (2019) |
Some mechanisms of immunotropic and adaptogenous effect of phytopreparations |
(Rus)
|
|
Shur J.V., Shur V.Y., Samotrueva M.A.
|
| Vol 17, No 4 (2019) |
Orexins and the brain reinforcing systems |
(Rus)
|
|
Tissen I.Y., Lebedev A.A., Bychkov E.R., Lavrov N.V., Morozov V.I., Shabanov P.D.
|
| Vol 17, No 3 (2019) |
Eryptosis (quasi-apoptosis) the human red blood cells. Its role in medicinal therapy |
(Rus)
|
|
Vaschenko V.I., Vil’yaninov V.N.
|
| Vol 17, No 2 (2019) |
Modern ideas about the effect of exogenous antioxidants on the growth of malignant tumors |
(Rus)
|
|
Puzakov K.K., Durnova N.A., Ryzhenkova I.G.
|
| Vol 17, No 2 (2019) |
Why do we need fullerenes today? |
(Rus)
|
|
Piotrovsky L.B., Litasova E.V., Dumpis M.A.
|
| Vol 17, No 2 (2019) |
Breach of ligand-receptor interaction in pathogenesis of disadaptive disorders and in pathology |
(Rus)
|
|
Artemenkov A.A.
|
| Vol 17, No 1 (2019) |
Hypoxia and antihypoxants, focus on brain injury |
(Rus)
|
|
Shabanov P.D., Zarubina I.V.
|
| Vol 17, No 1 (2019) |
Enhancement of physical endurance in animals by means of compounds with thiourea group (review of literature) |
(Rus)
|
|
Marysheva V.V., Shabanov P.D.
|
| 1 - 52 of 52 Items |
|
